CLLS
Price
$1.58
Change
-$0.07 (-4.24%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
150.58M
28 days until earnings call
SLN
Price
$5.52
Change
-$0.17 (-2.99%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
226.71M
42 days until earnings call
Interact to see
Advertisement

CLLS vs SLN

Header iconCLLS vs SLN Comparison
Open Charts CLLS vs SLNBanner chart's image
Cellectis SA
Price$1.58
Change-$0.07 (-4.24%)
Volume$226
Capitalization150.58M
Silence Therapeutics
Price$5.52
Change-$0.17 (-2.99%)
Volume$1.71K
Capitalization226.71M
CLLS vs SLN Comparison Chart in %
Loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLLS vs. SLN commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a Buy and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CLLS: $1.65 vs. SLN: $5.61)
Brand notoriety: CLLS and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 197% vs. SLN: 56%
Market capitalization -- CLLS: $150.58M vs. SLN: $226.71M
CLLS [@Biotechnology] is valued at $150.58M. SLN’s [@Biotechnology] market capitalization is $226.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • CLLS’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLN is a better buy in the long-term than CLLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 5 TA indicator(s) are bullish while SLN’s TA Score has 3 bullish TA indicator(s).

  • CLLS’s TA Score: 5 bullish, 5 bearish.
  • SLN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CLLS is a better buy in the short-term than SLN.

Price Growth

CLLS (@Biotechnology) experienced а +10.00% price change this week, while SLN (@Biotechnology) price change was -7.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

CLLS is expected to report earnings on Jul 31, 2025.

SLN is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($227M) has a higher market cap than CLLS($151M). CLLS YTD gains are higher at: -8.333 vs. SLN (-18.459). CLLS has higher annual earnings (EBITDA): -32.49M vs. SLN (-71.65M). CLLS has more cash in the bank: 242M vs. SLN (137M). SLN has less debt than CLLS: SLN (60K) vs CLLS (91.8M). CLLS has higher revenues than SLN: CLLS (47.6M) vs SLN (27.7M).
CLLSSLNCLLS / SLN
Capitalization151M227M67%
EBITDA-32.49M-71.65M45%
Gain YTD-8.333-18.45945%
P/E RatioN/AN/A-
Revenue47.6M27.7M172%
Total Cash242M137M177%
Total Debt91.8M60K153,000%
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLLSSLN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 3 days ago
89%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GFKRF0.01N/A
N/A
Opus One Gold Corp.
HMRZF13.54N/A
N/A
Hennes & Mauritz AB
PAIOF0.01N/A
N/A
Paion AG
SGLMF0.36N/A
N/A
Starhill Global Real Estate Investment Trust
MCHVF1.51-0.07
-4.43%
MGM China Holdings, Ltd.